D.MontineT
In our study, participants received rescue orforglipron if they experienced 50% or more weight regain while on placebo starting at 24 weeks post-randomization
While Ozempic and other GLP-1 medications are primarily used to manage type 2 diabetes, they have been associated with severe digestive issues such as gastroparesis, a condition that delays stomach emptying, leading to chronic nausea, vomiting, and malnutrition
Furthermore, BPC-157 appeared to hasten the dispersion of tendon fibroblasts across culture plates
As a result, their popularity has surged, with many individuals seeking to use them as weight management tools, either for an off-label use or an approved indication
However, New Hampshire lawmakers recently introduced a bill (SB455-FN) that would, if passed, require certain fully insured commercial health plans to cover GLP-1 medications under certain circumstances